Nifty
Sensex
:
:
16121.60
54052.61
-93.10 (-0.57%)
-236.00 (-0.43%)

Pharmaceuticals & Drugs - Global

Rating :
57/99

BSE: 500087 | NSE: CIPLA

970.05
23-May-2022
  • Open
  • High
  • Low
  • Previous Close
  •  978.80
  •  987.70
  •  966.45
  •  978.40
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  1220231
  •  11934.26
  •  1083.00
  •  850.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 78,309.37
  • 31.00
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 78,663.70
  • 0.52%
  • 3.74

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 33.63%
  • 0.83%
  • 15.54%
  • FII
  • DII
  • Others
  • 26.65%
  • 21.69%
  • 1.66%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 10.56
  • 5.89
  • 5.40

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 9.86
  • 11.41
  • 8.18

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 7.80
  • 18.99
  • 16.10

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 33.25
  • 32.10
  • 29.59

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 3.66
  • 3.38
  • 3.41

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 17.14
  • 15.30
  • 14.73

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 22
Mar 21
Var%
Dec 21
Dec 20
Var%
Sep 21
Sep 20
Var%
Jun 21
Jun 20
Var%
Net Sales
5,260.33
4,606.45
14.19%
5,478.86
5,168.69
6.00%
5,519.80
5,038.29
9.56%
5,504.35
4,346.16
26.65%
Expenses
4,510.61
3,810.21
18.38%
4,247.89
3,937.81
7.87%
4,293.60
3,861.72
11.18%
4,158.46
3,297.42
26.11%
EBITDA
749.72
796.24
-5.84%
1,230.97
1,230.88
0.01%
1,226.20
1,176.57
4.22%
1,345.89
1,048.74
28.33%
EBIDTM
14.25%
17.29%
22.47%
23.81%
22.21%
23.35%
24.45%
24.13%
Other Income
64.02
60.13
6.47%
91.29
86.94
5.00%
60.67
53.47
13.47%
64.93
65.45
-0.79%
Interest
18.10
27.45
-34.06%
20.68
47.92
-56.84%
38.00
39.33
-3.38%
29.57
46.00
-35.72%
Depreciation
290.31
285.19
1.80%
247.47
248.43
-0.39%
253.06
265.06
-4.53%
261.11
268.98
-2.93%
PBT
447.83
543.73
-17.64%
1,054.11
1,021.47
3.20%
995.81
925.65
7.58%
995.52
799.21
24.56%
Tax
71.11
128.22
-44.54%
295.16
268.96
9.74%
283.81
263.80
7.59%
283.72
227.78
24.56%
PAT
376.72
415.51
-9.34%
758.95
752.51
0.86%
712.00
661.85
7.58%
711.80
571.43
24.56%
PATM
7.16%
9.02%
13.85%
14.56%
12.90%
13.14%
12.93%
13.15%
EPS
4.49
5.13
-12.48%
9.03
9.28
-2.69%
8.82
8.25
6.91%
8.86
7.17
23.57%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Net Sales
21,763.34
19,159.59
17,131.99
16,362.41
15,155.71
14,394.29
13,594.89
11,345.44
10,173.39
8,279.33
7,020.71
Net Sales Growth
13.59%
11.84%
4.70%
7.96%
5.29%
5.88%
19.83%
11.52%
22.88%
17.93%
 
Cost Of Goods Sold
8,495.60
7,351.89
5,991.42
5,784.49
5,438.42
5,317.12
5,089.86
4,270.63
3,874.83
2,952.61
2,739.30
Gross Profit
13,267.74
11,807.70
11,140.57
10,577.92
9,717.29
9,077.17
8,505.03
7,074.81
6,298.56
5,326.72
4,281.41
GP Margin
60.96%
61.63%
65.03%
64.65%
64.12%
63.06%
62.56%
62.36%
61.91%
64.34%
60.98%
Total Expenditure
17,210.56
14,910.94
13,951.18
13,494.26
12,702.32
11,918.50
11,115.22
9,183.74
8,040.34
6,081.48
5,361.86
Power & Fuel Cost
-
308.26
327.43
335.11
298.82
251.73
245.92
228.28
218.63
233.12
235.35
% Of Sales
-
1.61%
1.91%
2.05%
1.97%
1.75%
1.81%
2.01%
2.15%
2.82%
3.35%
Employee Cost
-
3,251.83
3,027.01
2,856.53
2,690.10
2,633.82
2,434.01
1,967.72
1,542.96
1,036.02
772.50
% Of Sales
-
16.97%
17.67%
17.46%
17.75%
18.30%
17.90%
17.34%
15.17%
12.51%
11.00%
Manufacturing Exp.
-
1,206.33
1,372.03
1,284.94
1,220.67
1,192.77
1,023.49
737.11
644.42
541.58
583.18
% Of Sales
-
6.30%
8.01%
7.85%
8.05%
8.29%
7.53%
6.50%
6.33%
6.54%
8.31%
General & Admin Exp.
-
986.01
1,289.13
1,096.50
1,002.43
868.31
845.89
743.46
638.08
496.81
369.85
% Of Sales
-
5.15%
7.52%
6.70%
6.61%
6.03%
6.22%
6.55%
6.27%
6.00%
5.27%
Selling & Distn. Exp.
-
1,298.62
1,252.04
1,281.29
1,082.90
1,009.21
818.76
738.87
680.32
466.22
467.61
% Of Sales
-
6.78%
7.31%
7.83%
7.15%
7.01%
6.02%
6.51%
6.69%
5.63%
6.66%
Miscellaneous Exp.
-
508.00
692.12
855.40
968.98
645.54
657.29
497.67
441.10
355.12
467.61
% Of Sales
-
2.65%
4.04%
5.23%
6.39%
4.48%
4.83%
4.39%
4.34%
4.29%
2.76%
EBITDA
4,552.78
4,248.65
3,180.81
2,868.15
2,453.39
2,475.79
2,479.67
2,161.70
2,133.05
2,197.85
1,658.85
EBITDA Margin
20.92%
22.18%
18.57%
17.53%
16.19%
17.20%
18.24%
19.05%
20.97%
26.55%
23.63%
Other Income
280.91
269.77
369.38
476.57
357.65
228.69
208.21
165.55
265.37
222.14
139.52
Interest
106.35
160.70
197.36
168.43
114.23
159.38
206.63
168.29
145.74
33.91
38.34
Depreciation
1,051.95
1,067.66
1,174.65
1,097.15
949.83
1,322.93
754.22
504.71
372.64
330.48
312.22
PBT
3,493.27
3,290.06
2,178.18
2,079.14
1,746.98
1,222.17
1,727.03
1,654.25
1,880.04
2,055.60
1,447.81
Tax
933.80
888.76
631.20
569.53
250.11
179.76
331.59
400.03
463.38
544.31
306.51
Tax Rate
26.73%
27.01%
28.98%
27.39%
14.98%
14.71%
19.20%
24.18%
24.65%
25.98%
21.17%
PAT
2,559.47
2,417.66
1,593.98
1,544.87
1,413.31
1,013.38
1,372.01
1,206.07
1,400.73
1,551.06
1,141.30
PAT before Minority Interest
2,529.57
2,401.30
1,546.98
1,509.61
1,419.35
1,042.41
1,395.44
1,254.22
1,416.66
1,551.06
1,141.30
Minority Interest
-29.90
16.36
47.00
35.26
-6.04
-29.03
-23.43
-48.15
-15.93
0.00
0.00
PAT Margin
11.76%
12.62%
9.30%
9.44%
9.33%
7.04%
10.09%
10.63%
13.77%
18.73%
16.26%
PAT Growth
6.59%
51.67%
3.18%
9.31%
39.46%
-26.14%
13.76%
-13.90%
-9.69%
35.90%
 
EPS
31.92
30.15
19.88
19.27
17.62
12.64
17.11
15.04
17.47
19.34
14.23

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Shareholder's Funds
18,326.53
15,763.00
15,012.28
14,229.19
12,543.66
11,516.22
10,801.49
10,050.35
9,018.68
7,638.93
Share Capital
161.29
161.25
161.14
161.02
160.90
160.68
160.59
160.58
160.58
160.58
Total Reserves
18,123.15
15,548.70
14,794.10
14,001.91
12,320.74
11,266.12
10,557.74
9,868.12
8,858.10
7,478.35
Non-Current Liabilities
1,660.06
2,972.37
4,646.15
4,259.05
4,514.99
1,407.13
2,417.66
2,028.05
1,024.96
824.27
Secured Loans
355.32
304.74
47.70
0.00
0.00
207.00
287.09
317.44
0.00
0.00
Unsecured Loans
847.43
2,064.54
3,782.37
3,662.11
3,645.36
14.88
22.19
0.43
0.55
3.25
Long Term Provisions
116.17
133.27
121.41
137.92
140.52
144.68
1,783.17
1,368.64
713.87
557.78
Current Liabilities
4,591.55
4,393.14
3,771.51
3,832.22
3,388.91
7,776.05
3,881.13
2,563.58
2,277.63
1,413.19
Trade Payables
2,066.82
2,281.81
1,947.99
2,119.12
1,586.30
1,475.82
1,452.06
979.53
828.36
691.77
Other Current Liabilities
1,093.62
706.65
541.86
647.04
908.95
1,006.14
654.55
408.67
250.89
489.93
Short Term Borrowings
334.73
447.15
486.16
435.87
467.23
4,969.67
1,392.48
910.47
966.38
10.20
Short Term Provisions
1,096.38
957.53
795.50
630.19
426.43
324.42
382.04
264.91
232.00
221.29
Total Liabilities
24,837.20
23,422.79
23,761.91
22,672.90
20,885.79
21,049.49
17,280.76
14,691.56
12,321.27
9,876.39
Net Block
9,393.77
9,558.59
9,546.51
9,949.14
9,508.16
9,368.32
6,829.64
6,496.47
3,609.97
3,215.49
Gross Block
15,735.87
14,913.62
13,790.31
12,960.01
11,370.70
10,167.62
9,561.55
8,676.27
5,317.52
4,626.35
Accumulated Depreciation
6,305.64
5,309.30
4,233.78
3,010.87
1,609.71
799.30
2,731.91
2,179.80
1,707.55
1,410.86
Non Current Assets
11,627.69
11,716.61
11,335.28
11,858.80
12,082.23
12,208.26
9,689.47
9,039.59
5,537.29
4,819.58
Capital Work in Progress
968.89
824.53
676.18
981.33
1,682.98
2,060.87
580.90
441.84
377.79
371.17
Non Current Investment
545.43
578.80
490.20
157.66
137.36
176.35
249.76
397.14
415.69
328.59
Long Term Loans & Adv.
645.57
677.08
455.57
514.96
543.67
426.18
1,860.29
1,545.25
971.75
857.53
Other Non Current Assets
74.03
77.61
166.82
255.71
210.06
176.54
168.88
158.89
162.09
46.80
Current Assets
13,209.51
11,706.18
12,426.63
10,814.10
8,803.56
8,841.23
7,591.29
5,651.97
6,783.98
5,056.81
Current Investments
2,286.37
1,016.52
2,125.79
1,102.21
837.39
582.34
390.02
311.43
2,116.75
940.52
Inventories
4,669.18
4,377.60
3,964.83
4,044.70
3,519.72
3,808.05
3,780.62
2,895.26
2,387.07
1,850.08
Sundry Debtors
3,445.68
3,891.31
4,150.72
3,102.45
2,582.17
2,356.27
1,997.72
1,638.89
1,668.84
1,553.58
Cash & Bank
1,401.23
1,003.91
618.81
965.61
638.27
871.40
564.26
175.76
143.01
90.46
Other Current Assets
1,407.05
442.02
415.53
480.20
1,226.01
1,223.17
858.67
630.63
468.31
622.17
Short Term Loans & Adv.
1,031.03
974.82
1,150.95
1,118.93
807.84
780.03
713.07
595.13
463.21
459.94
Net Current Assets
8,617.96
7,313.04
8,655.12
6,981.88
5,414.65
1,065.18
3,710.16
3,088.39
4,506.35
3,643.62
Total Assets
24,837.20
23,422.79
23,761.91
22,672.90
20,885.79
21,049.49
17,280.76
14,691.56
12,321.27
9,876.39

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Cash From Operating Activity
3,755.20
3,068.45
1,691.14
1,462.76
2,381.76
1,740.81
1,173.43
1,563.31
1,397.67
1,712.76
PBT
3,290.06
2,178.18
2,079.14
1,669.46
1,222.17
1,727.03
1,654.25
1,880.04
2,095.38
1,447.81
Adjustment
1,130.91
1,365.53
1,268.77
1,293.82
1,374.42
950.85
630.05
552.80
283.82
396.66
Changes in Working Capital
371.66
372.99
-1,063.54
-778.48
235.44
-429.38
-718.61
-561.26
-519.84
199.76
Cash after chg. in Working capital
4,792.63
3,916.70
2,284.37
2,184.80
2,832.03
2,248.50
1,565.69
1,871.58
1,859.36
2,044.23
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-1,037.43
-848.25
-593.23
-722.04
-450.27
-507.69
-392.26
-308.27
-461.69
-331.47
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-2,387.18
104.04
-1,668.68
-854.01
-1,310.21
-4,522.63
-941.15
-1,249.86
-2,062.89
-965.10
Net Fixed Assets
-466.10
-450.41
-173.16
-509.84
-889.04
1,487.25
-534.38
-437.26
-692.52
-460.09
Net Investments
-2,533.43
-1,439.15
-1,239.74
-351.09
-30.10
164.99
-833.97
-985.31
-1,566.67
-464.50
Others
612.35
1,993.60
-255.78
6.92
-391.07
-6,174.87
427.20
172.71
196.30
-40.51
Cash from Financing Activity
-1,329.90
-2,948.82
-348.72
-385.48
-1,325.68
3,104.06
164.78
-265.63
717.77
-753.17
Net Cash Inflow / Outflow
38.12
223.67
-326.26
223.27
-254.13
322.24
397.06
47.82
52.55
-5.51
Opening Cash & Equivalents
742.38
508.36
853.47
610.35
858.15
545.84
175.76
143.01
90.46
95.97
Closing Cash & Equivalent
793.29
742.38
508.36
853.46
610.35
858.15
564.26
175.76
143.01
90.46

Financial Ratios

Consolidated /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Book Value (Rs.)
226.73
194.85
185.62
175.92
155.15
142.23
133.38
124.79
112.21
95.03
ROA
9.95%
6.56%
6.50%
6.52%
4.97%
7.28%
7.85%
10.49%
13.97%
12.05%
ROE
14.13%
10.09%
10.37%
10.65%
8.72%
12.61%
12.10%
14.89%
18.64%
15.98%
ROCE
17.85%
12.53%
11.94%
10.20%
8.28%
13.24%
15.33%
19.05%
24.15%
19.96%
Fixed Asset Turnover
1.84
1.89
1.79
1.25
1.36
1.40
1.26
1.47
1.69
1.61
Receivable days
47.44
54.10
55.36
68.17
61.60
57.62
57.94
58.66
70.11
77.94
Inventory Days
58.49
56.12
61.13
90.71
91.41
100.43
106.36
93.68
92.19
96.16
Payable days
107.95
128.84
59.02
57.37
46.96
51.51
52.17
44.93
48.58
50.51
Cash Conversion Cycle
-2.02
-18.63
57.47
101.50
106.05
106.55
112.14
107.41
113.72
123.59
Total Debt/Equity
0.10
0.18
0.29
0.29
0.33
0.46
0.16
0.12
0.11
0.00
Interest Cover
21.47
12.04
13.34
15.61
8.67
9.36
10.83
13.90
62.79
38.76

News Update:


  • Cipla reports 10% fall in Q4 consolidated net profit
    11th May 2022, 10:54 AM

    The company has reported a standalone net profit of Rs 476.30 crore for the quarter ended March 31, 2022

    Read More
  • Cipla launches ‘RT-Direct’ multiplex COVID-19 RT PCR Test kit in India
    10th May 2022, 09:34 AM

    This kit is validated at the Indian Council of Medical Research approved Centre

    Read More
  • Cipla’s two promoters offload 2.5% stake
    15th Feb 2022, 16:45 PM

    Post this transaction, the promoter group will continue to hold 34.23 per cent in the company

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.